Bimetallic NiCu‐MOF Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Suppressing Ferroptosis and Inflammation
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202405175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Lu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Department of Developmental & Regener…. Hauptthemen laut MEDLINE: Ferroptosis, Metal-Organic Frameworks, Doxorubicin, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University.
Themen: Neonatologie
Abstract (Originalsprache)
Doxorubicin (DOX), a potent anthracycline chemotherapeutic agent, is widely used in cancer treatment but is associated with significant adverse effects, particularly DOX‐induced cardiomyopathy (DIC). DIC pathogenesis involves the generation of reactive oxygen species (ROS) and ferroptosis induction. Novel therapeutic strategies targeting antioxidant defenses and ferroptosis inhibition are essential for mitigating DIC. An innovative bimetallic metal‐organic framework (MOF), NiCu‐MOF (NCM), is developed, exhibiting multifaceted antioxidant enzyme‐mimicking activities that effectively scavenge a broad spectrum of ROS. Additionally, the bimetallic NCM exhibits excellent iron‐chelating ability. In vitro experiments demonstrate that NCM significantly reduces cardiomyocyte death by attenuating ROS levels and inhibiting ferroptosis. Furthermore, in a mouse model of DIC, NCM treatment results in substantial myocardial protection, evidenced by improved cardiac function and structural integrity. This protective effect is attributed to suppression of ferroptosis, preservation of mitochondrial function, and attenuation of inflammatory responses. Collectively, these findings highlight biocompatible NCM's potential as a novel cardioprotective agent and offer a promising therapeutic strategy for managing DIC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Department of Developmental & Regenerative Medicine, College of Life Science and Technology, Jinan Universi…
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.
Förderung
- National Key Research and Development Program of China
- Research Grant of Key Laboratory of Regenerative Medicine
- Ministry of Education, Jinan University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liu, L., Chao, D., Dong, Q., Zhang, X., Zhang, K., & Ju, Z. (2025). Bimetallic NiCu‐MOF Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Suppressing Ferroptosis and Inflammation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202405175
Vancouver
Liu L, Chao D, Dong Q, Zhang X, Zhang K, Ju Z. Bimetallic NiCu‐MOF Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Suppressing Ferroptosis and Inflammation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202405175
BibTeX
@article{Liu2025,
author = {Liu, Lu and Chao, Daiyong and Dong, Qing and Zhang, Xianli and Zhang, Kai and Ju, Zhenyu},
title = {Bimetallic NiCu‐MOF Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Suppressing Ferroptosis and Inflammation},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202405175}
}
EUVIMED